Sarah Blagden

Associate professor of experimental cancer therapeutics, Medical Sciences Division, University of Oxford

  • Medical Sciences Divisional Office University of Oxford Level 3, John Radcliffe Hospital Oxford OX3 9DU
  • www.oncology.ox.ac.uk


Biography

Following medical training and subsequent specialist training in Medical Oncology at Addenbrooke’s Hospital in Cambridge and the Royal Marsden Hospital, Sarah was awarded a CRUK Junior Clinician Scientist PhD fellowship in 1999 at Cambridge University and held a Clinical Fellowship at the Institute of Cancer Research’s Drug Development Unit.

She was appointed as Senior Lecturer and Honorary Consultant at Imperial College in 2006 and became Director of Imperial’s Early Cancer Trials Unit and established her laboratory studying the dysregulation of mRNA translation in cancer. She has been chief or principal investigator for a number of national and international clinical studies.

Education & Experience


Education

Title:
MBBS
Degree:
Medical Degree
Institution:
Charing Cross and Westminster Medical School, University of London
Date:
2000 - 2004
Country:
United Kingdom
Title:
PhD
Degree:
CRUK Clinical Fellow
Institution:
Cambridge University
Date:
2000 - 2004
Country:
United Kingdom


Experience



Location

  • Medical Sciences Divisional Office University of Oxford Level 3, John Radcliffe Hospital Oxford OX3 9DU